Carcinoma: all 6,718 studies
Page 43 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCompletedNCT03329950Phase 1
- Comparison of SBRTand Repeat TACE for HCCStatus unknownNCT03326375Not applicable
- Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective StudyCompletedNCT03325738
- Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT03325465Phase 2
- Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)CompletedNCT03324373Phase 1
- Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell CarcinomaWithdrawnNCT03323710Phase 2
- TACE Combined With Iodine-125 Seeds Implantation for HCCStatus unknownNCT03322280Not applicable
- EPR Tumor Oximetry With CE India InkTerminatedNCT03321903
- Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal CarcinomaActive, not recruitingNCT03321539Phase 3
- PSMA-PET Imaging for Advanced ACC/SDCCompletedNCT03319641Not applicable
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCCTerminatedNCT03318562Phase 2
- Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal CarcinomaStatus unknownNCT03318185Not applicable
- Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCompletedNCT03317119Phase 1
- The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT03314532Not applicable
- Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNACompletedNCT03314051
- Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCCStatus unknownNCT03313596Phase 3
- A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial CarcinomaWithdrawnNCT03310567Phase 2
- Fractional CO2 Laser Therapy for Survivors of Breast MalignanciesCompletedNCT03307044Not applicable
- TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal CarcinomaActive, not recruitingNCT03306121Phase 3
- Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)CompletedNCT03305133
- Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian CarcinomaStatus unknownNCT03302884Not applicable
- Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant TumorsStatus unknownNCT03302403Not applicable
- Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 RadioembolizationWithdrawnNCT03300401Not applicable
- Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT03299946Phase 1
- Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell CarcinomaCompletedNCT03297593Phase 2
- Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian CancerCompletedNCT03297489Early Phase 1
- Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial CarcinomaStatus unknownNCT03296306Phase 3
- A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCCCompletedNCT03295006
- Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell LineCompletedNCT03292822Phase 1
- Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCStatus unknownNCT03291002Phase 1
- Itch and Pain Characteristics in Skin CarcinomasCompletedNCT03290989
- Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03290820Phase 2
- The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma PatientsStatus unknownNCT03290001
- Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)CompletedNCT03289273
- Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell LineStatus unknownNCT03288298Early Phase 1
- MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies TrialCompletedNCT03287427Phase 1
- Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -CompletedNCT03287375Phase 2
- Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular CarcinomaStatus unknownNCT03285867
- Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in TaiwanStatus unknownNCT03283956
- PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.Status unknownNCT03283943Phase 1
- Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRTCompletedNCT03283293Phase 2
- Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck CancerCompletedNCT03281499Not applicable
- Denosumab and Pembrolizumab in Clear Cell Renal CarcinomaStatus unknownNCT03280667Phase 2
- Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine CarcinomaStatus unknownNCT03279614Phase 2
- Avelumab in G3 NECCompletedNCT03278405Phase 1/2
- Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma HugeStatus unknownNCT03277716Not applicable
- A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCCTerminatedNCT03276819Not applicable
- Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck CancerCompletedNCT03268993Not applicable
- Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular CarcinomaCompletedNCT03267641
- Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
- A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT03267121Phase 2
- A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free SurvivalTerminatedNCT03266900Early Phase 1
- Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical ResectionStatus unknownNCT03261791Phase 2
- RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCCStatus unknownNCT03259477Not applicable
- Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy LinesStatus unknownNCT03257891Phase 2
- Detecting Transitional Cell Carcinoma From HaematuriaCompletedNCT03256877
- Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological ResponseCompletedNCT03254121
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric CancerCompletedNCT03253939
- Meclizine for Hepatocellular CarcinomaCompletedNCT03253289Phase 1
- The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by ResectionStatus unknownNCT03253250Phase 4
- Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRCCompletedNCT03253133Phase 1
- Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell CarcinomaTerminatedNCT03251417Phase 2
- Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SDTerminatedNCT03246685Phase 2
- Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTCCompletedNCT03246659Phase 1
- PIPAC for Peritoneal Metastases of Colorectal CancerCompletedNCT03246321Phase 2
- Study of Chiauranib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT03245190Phase 1/2
- Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCCStatus unknownNCT03243916Not applicable
- Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT03240393Phase 2
- Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder TumorsWithdrawnNCT03238664Not applicable
- The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma SubjectsTerminatedNCT03236649Phase 3
- The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma SubjectsStatus unknownNCT03236636Phase 3
- Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination TherapyStatus unknownNCT03235167Phase 1
- Hepatocellular Carcinoma Registry in Asia: The INSIGHT RegistryCompletedNCT03233360
- A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)CompletedNCT03232593
- Immunologic Profile of Peritoneal CancerStatus unknownNCT03230240
- Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)Status unknownNCT03230201Not applicable
- MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali PatientsStatus unknownNCT03227510
- TRACERx Renal CAPTURE Sub-studyStatus unknownNCT03226886
- New Modalities for Detection of Oropharyngeal CancerCompletedNCT03226613Not applicable
- PEN-866 in Patients With Advanced Solid MalignanciesStatus unknownNCT03221400Phase 1/2
- Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWithdrawnNCT03220009Phase 2
- Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell CarcinomaStatus unknownNCT03219775Phase 2
- Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionWithdrawnNCT03217253Phase 1
- Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Status unknownNCT03213587Phase 2
- The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin ReactionCompletedNCT03212625Phase 4
- A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic CancerCompletedNCT03212469Phase 1/2
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
- Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction CarcinomaStatus unknownNCT03211377
- The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder RecurrenceStatus unknownNCT03209206Phase 2
- Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based ChemotherapyTerminatedNCT03208712Early Phase 1
- Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular ProfilingActive, not recruitingNCT03208374
- Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)Status unknownNCT03208335Phase 2
- Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)SuspendedNCT03208296Phase 1/2
- Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerCompletedNCT03207529Phase 1
- NCI UNC Project ESCCTerminatedNCT03206125
- Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®TerminatedNCT03203837
- Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver CancerTerminatedNCT03203304Phase 1
- IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma PatientsCompletedNCT03203005Phase 1/2
- The Diagnosis of NPC Using the Probe-based Confocal Laser EndomicroscopyStatus unknownNCT03202173Not applicable